By Associate Professor Chaturaka Rodrigo

Conference Abstracts

Howe A; De Salazar A; Aragri M; Popping S; Fourati S; Tay E; Rodrigo C; Cunningham E; Kjellin M; Fernando Fay F; Newton E; Sfalcin J; Gomes P; Boucher CA; De Knegt R; Poljak M; Lunar M; Salmon D; Usubillaga R; Sayan M; Mor O; Seguin-Devaux C; Lloyd A; Pawlotsky J-M; Grebely J; Lennerstrand J; Knops E; Kaiser R; Chulanov V; Rincon P; Martinez-Sapina A; Galera C; Douglas M; Silberstein FC; Harrigan R; Garcia Garcia F, 2019, 'GENOTYPE MISCLASSIFICATION NEGATIVELY IMPACT THE CHOICE OF REGIMENS AND TREATMENT OUTCOMES IN THE MANAGEMENT OF HEPATITIS C', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 318A - 319A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653501070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fourati S; Silberstein FC; Howe A; De Salazar A; Popping S; Di Maio VC; Tay E; Rodrigo C; Cunningham E; Kjellin M; Sfalcin J; Gomes P; Poljak M; Lunar M; Sayan M; Mor O; Salmon D; Usubillaga R; Seguin-Devaux C; Boucher CA; Poiteau L; Lloyd A; Grebely J; Lennerstrand J; Kaiser R; Zhigalkina P; Fernando Fay F; Aragri M; Chulanov V; Garcia-Deltoro M; Cabezas J; Carlos Alados J; De Knegt RJ; Douglas M; Garcia FG; Harrigan R; Pawlotsky J-M, 2019, 'HCV RESISTANCE PATTERNS IN A WORLDWIDE NETWORK OF COHORTS OF GT-3a INFECTED PATIENTS', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 180A - 181A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500277&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Popping S; Fourati S; Howe A; Di Maio VC; Tay E; Rodrigo C; Cunningham E; Kjellin M; Sfalcin J; Gomes P; Poljak M; Lunar M; Sayan M; Mor O; Salmon D; Usubillaga R; Omar M; Garcia-Bujalance S; Tellez F; Fuentes A; Seguin-Devaux C; Soulier A; Lloyd A; Grebely J; Aragri M; Lennerstrand J; Kaiser R; Zhigalkina P; Chulanov V; De Knegt RJ; Douglas M; Silberstein FC; Harrigan R; Garcia FG; Boucher CA; Pawlotsky J-M, 2019, 'THE GLOBAL PREVALENCE OF RESISTANCE ASSOCIATED SUBSTITUTIONS (RASS) IN "UNUSUAL" HCV SUBTYPES', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 77A - 78A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Crawford LC; Whybrow D; Rodrigo C; Riaz N; Higgins G, 2019, 'The first patient with hepatitis C genotype 8 infection in Australia', in Pathology, Elsevier BV, Vol. 51, pp. S135 - S135, http://dx.doi.org/10.1016/j.pathol.2018.12.391

Preprints

Adhikari A; Abayasingam A; A NB; Kim HN; Lord M; Agapiou D; Maher L; Rodrigo C; Lloyd A; Bull R; Tedla N, 2023, Characterisation of antibody dependent cellular phagocytosis in patients infected with Hepatitis C virus with different clinical outcomes, http://dx.doi.org/10.22541/au.168992839.95818489/v1

Herath HMMTB; Rodrigo C; Alahakoon AMBD; Ambawatte SB; Senanayake S; Senanayake B; Fernando A, 2021, Outcomes of Stroke Patients Undergoing Thrombolysis in Sri Lanka; an Observational Prospective Study From a Low-middle Income Country, http://dx.doi.org/10.21203/rs.3.rs-751515/v1

Adhikari A; Abayasingam A; Rodrigo C; Agapiou D; Pandzic E; Brasher N; Madushan Fernando BS; Keoshkerian E; Li H; Kim HN; Lord M; Popovic G; Rawlinson W; Mina M; Post J; Hudson B; Gilroy N; Bartlett A; Ahlenstiel G; Grubor-Bauk B; Dwyer D; Konecny P; Lloyd A; Martinello M; Bull R; Tedla N, 2021, Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection, http://dx.doi.org/10.1101/2021.12.21.473774

Bull R; Abayasingam A; Balachandran H; Agapiou D; Rodrigo C; Keoshkerian E; Li H; Brasher N; Christ D; Rouet R; Burnett D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Brilot F; Mina M; Post J; Hudson B; Gilroy N; Dwyer D; Sasson S; Tea F; Pilli D; Tedla N; Lloyd A; Martinello M, 2020, Long-term persistence of neutralizing memory B cells in SARS-CoV-2, http://dx.doi.org/10.21203/rs.3.rs-92527/v1

Abayasingam A; Balachandran H; Agapiou D; Rodrigo C; Keoshkerian E; Li H; Brasher N; Christ D; Rouet R; Burnett D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson S; Tea F; Pilli D; Tedla N; Lloyd AR; Martinello M; Bull RA; Group COSINS, Long-Term Persistence of Neutralizing Memory B Cells in SARS-CoV-2, http://dx.doi.org/10.2139/ssrn.3732365

Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson S; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer D; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses, http://dx.doi.org/10.2139/ssrn.3920641

Other

Rodrigo C, 2021, Exploring the complexity of RNA virus infections using viral genomics, Sri Lanka Journals Online (JOL), http://dx.doi.org/10.4038/jccp.v52i2.7939

Rodrigo C, 2020, For people with intestinal helminths, what is the effect of anthelmintic drugs?, Wiley, http://dx.doi.org/10.1002/cca.3139

Rodrigo C, 2020, How do different anthelmintic drug regimens compare for treating ascariasis?, Wiley, http://dx.doi.org/10.1002/cca.3141

Rodrigo C, 2019, What are the effects of deworming drugs for children living in endemic areas?, Wiley, http://dx.doi.org/10.1002/cca.2726

Rodrigo C, 2019, What are the benefits and harms of deworming drugs in children living in soil-transmitted intestinal worm endemic areas?, Wiley, http://dx.doi.org/10.1002/cca.943

Rodrigo C, 2019, What adverse events can people taking macrolide antibiotics experience?, Wiley, http://dx.doi.org/10.1002/cca.2437

Rodrigo C, 2019, What are the effects of albendazole alone or in combination with microfilaricidal drugs for people with lymphatic filariasis?, Wiley, http://dx.doi.org/10.1002/cca.2451

Rodrigo C, 2018, How does oral ivermectin compare with topical permethrin for people with scabies?, Wiley, http://dx.doi.org/10.1002/cca.2156

Rodrigo C, 2018, What are the benefits and harms of smectite (diosmectite) for children with acute infectious diarrhea?, Wiley, http://dx.doi.org/10.1002/cca.2146

Rodrigo C, 2018, What are the effects of face-to-face interventions for informing or educating parents about early childhood vaccination?, Wiley, http://dx.doi.org/10.1002/cca.2193

Rodrigo C, 2018, What are the effects of probiotics for adults and children being treated with antibiotics?, Wiley, http://dx.doi.org/10.1002/cca.2047

Rodrigo C, 2016, How do community-level interventions affect the use of condoms for the prevention of HIV and other sexually transmitted infections?, Wiley, http://dx.doi.org/10.1002/cca.1137

Rodrigo C, 2016, How does the timing of initiation of antiretroviral therapy affect outcomes in HIV-infected, treatment-naive children aged 2 to 5 years?, Wiley, http://dx.doi.org/10.1002/cca.1084

Back to profile page